NasdaqGM - Nasdaq Real Time Price USD

XOMA Royalty Corporation (XOMAP)

25.63
+0.15
+(0.59%)
At close: May 15 at 4:00:00 PM EDT
Advanced Chart
Loading Chart for XOMAP
  • Previous Close 25.48
  • Open 25.63
  • Bid --
  • Ask --
  • Day's Range 25.63 - 25.63
  • 52 Week Range 24.96 - 26.51
  • Volume 1,175
  • Avg. Volume 1,601
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 25.61
  • EPS (TTM) 1.00
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield 2.16 (8.41%)
  • Ex-Dividend Date Apr 3, 2025
  • 1y Target Est --

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

www.xoma.com

13

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about XOMA Royalty Corporation

Recent News: XOMAP

View More
View More

Performance Overview: XOMAP

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

XOMAP
3.28%
S&P 500 (^GSPC)
0.60%

1-Year Return

XOMAP
10.29%
S&P 500 (^GSPC)
11.47%

3-Year Return

XOMAP
30.05%
S&P 500 (^GSPC)
47.05%

5-Year Return

XOMAP
2.94%
S&P 500 (^GSPC)
106.62%

Compare To: XOMAP

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

XOMAP
XOMA Royalty Corporation
25.63
+0.59%
Mkt Cap -
Industry Biotechnology
AVXL
Anavex Life Sciences Corp.
8.37
+2.45%
Mkt Cap 714.563M
Industry Biotechnology
NVAX
Novavax, Inc.
6.29
+5.54%
Mkt Cap 1.019B
Industry Biotechnology
MRNA
Moderna, Inc.
23.65
-1.54%
Mkt Cap 9.146B
Industry Biotechnology

Statistics: XOMAP

View More

Valuation Measures

Annual
As of

  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.66%

  • Return on Assets (ttm)

    -6.78%

  • Return on Equity (ttm)

    -3.42%

  • Revenue (ttm)

    42.91M

  • Net Income Avi to Common (ttm)

    -8.62M

  • Diluted EPS (ttm)

    1.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    92.65M

  • Total Debt/Equity (mrq)

    135.24%

  • Levered Free Cash Flow (ttm)

    -31.29M

View More

Research Analysis: XOMAP

View More

Revenue vs. Earnings

Revenue 15.91M
Earnings --

Q2'24

Q3'24

Q4'24

Q1'25

0
5M
10M
15M
 

Analyst Price Targets

 
View More

People Also Watch

XOMAO XOMA Royalty Corporation
25.03
-0.02%
 
FBIOP Fortress Biotech, Inc.
6.61
+5.76%
 
OXLCP Oxford Lane Capital Corp.
24.42
-0.12%
 
WTFCP Wintrust Financial Corporation
25.15
0.00%
 
WSBCP WesBanco, Inc.
25.20
+0.19%
 
STRRP Star Equity Holdings, Inc.
9.39
+2.23%
 
RILYP B. Riley Financial, Inc.
2.4792
+1.61%
 
NYMTM New York Mortgage Trust, Inc.
24.57
+0.29%
 
RILYL B. Riley Financial, Inc.
2.4200
+0.83%
 
ATLCP Atlanticus Holdings Corporation
23.10
+0.26%
 
WTFCM Wintrust Financial Corporation
25.07
-0.04%
 
WAFDP WaFd, Inc.
16.41
+0.43%
 
ZIONP Zions Bancorporation, National Association
23.20
+0.74%
 
PNFPP Pinnacle Financial Partners, Inc.
24.28
-0.33%
 
OTRKP Ontrak, Inc.
0.2311
0.00%
 
TDS-PU Telephone and Data Systems, Inc.
21.13
-0.28%